GE HealthCare Technologies EBIT

The latest EBIT for GEHC is $2.4B as of June 2026. That compares with $3.1B in the prior-year period — down 21.7% year over year. That is above the sector sector average of $-26M. Investors often review this figure alongside GE HealthCare Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, GEHC's EBIT moved from $3.1B to $2.4B — a 21.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GE HealthCare Technologies's operating scale or balance-sheet position.

Against its sector companies, GEHC currently prints $2.4B for EBIT, while the sector average sits near $-26M. That is roughly 9404.3% above the sector mean. Large gaps often invite a closer look at GE HealthCare Technologies's growth, margins, and balance sheet.

A EBIT figure of $2.4B for GEHC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-26M. Explore the charts below for those layers of context.

After noting GEHC's EBIT ($2.4B), review year-over-year change from $3.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.